Vincent Mwangi

Vincent Mwangi has extensive experience in the pharmaceutical industry, holding various leadership roles in major companies. Vincent began their career at GSK in 2001, where they served as the Director of Clinical Development R&D for twelve years. Following their time at GSK, Mwangi joined Pfizer in 2013, where they worked as the Director of Clinical Research. In 2014, they moved to Takeda and held positions such as Regional Medical Director and Senior Director of Clinical Program Management. Most recently, Mwangi joined Clover Biopharmaceuticals in 2020, where they have served as the Vice President of Clinical Operations/Medical Affairs for Vaccines, and later as the Vice President of Medical Affairs for Vaccines until 2023.

Vincent Mwangi obtained a Bachelor of Science degree from Saint Joseph's University in 1993 and later pursued a medical degree at the University of Pennsylvania, completing it in 2001.